دورية أكاديمية

N 6 -Methyladenosine Directly Regulates CD40L Expression in CD4 + T Lymphocytes.

التفاصيل البيبلوغرافية
العنوان: N 6 -Methyladenosine Directly Regulates CD40L Expression in CD4 + T Lymphocytes.
المؤلفون: van Vroonhoven ECN; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Picavet LW; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Scholman RC; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van den Dungen NAM; Department of Experimental Cardiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Mokry M; Department of Experimental Cardiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Evers A; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Lebbink RJ; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Calis JJA; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Vastert SJ; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Pediatric Rheumatology and Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van Loosdregt J; Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
المصدر: Biology [Biology (Basel)] 2023 Jul 14; Vol. 12 (7). Date of Electronic Publication: 2023 Jul 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101587988 Publication Model: Electronic Cited Medium: Print ISSN: 2079-7737 (Print) Linking ISSN: 20797737 NLM ISO Abbreviation: Biology (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, 2012-
مستخلص: T cell activation is a highly regulated process, modulated via the expression of various immune regulatory proteins including cytokines, surface receptors and co-stimulatory proteins. N 6 -methyladenosine (m 6 A) is an RNA modification that can directly regulate RNA expression levels and it is associated with various biological processes. However, the function of m 6 A in T cell activation remains incompletely understood. We identify m 6 A as a novel regulator of the expression of the CD40 ligand (CD40L) in human CD4 + lymphocytes. Manipulation of the m 6 A 'eraser' fat mass and obesity-associated protein (FTO) and m 6 A 'writer' protein methyltransferase-like 3 (METTL3) directly affects the expression of CD40L. The m 6 A 'reader' protein YT521-B homology domain family-2 (YTHDF2) is hypothesized to be able to recognize and bind m 6 A specific sequences on the CD40L mRNA and promotes its degradation. This study demonstrates that CD40L expression in human primary CD4 + T lymphocytes is regulated via m 6 A modifications, elucidating a new regulatory mechanism in CD4 + T cell activation that could possibly be leveraged in the future to modulate T cell responses in patients with immune-related diseases.
References: Cell Rep. 2022 Oct 25;41(4):111530. (PMID: 36288719)
Mediators Inflamm. 2019 Oct 24;2019:3120391. (PMID: 31772500)
Mol Cell. 2013 Jan 10;49(1):18-29. (PMID: 23177736)
Mol Cell. 2018 Sep 20;71(6):973-985.e5. (PMID: 30197295)
Bioinformatics. 2015 Jan 15;31(2):166-9. (PMID: 25260700)
Dis Markers. 2020 Jun 25;2020:8193895. (PMID: 32685056)
Nat Methods. 2015 Aug;12(8):767-72. (PMID: 26121403)
FEBS Lett. 2018 Jun;592(12):2012-2022. (PMID: 29754392)
Sci Rep. 2020 Apr 20;10(1):6590. (PMID: 32313079)
Nat Commun. 2021 Feb 26;12(1):1333. (PMID: 33637761)
Adv Drug Deliv Rev. 2019 Feb 15;141:92-103. (PMID: 30552917)
Nature. 2021 May;593(7860):597-601. (PMID: 33902106)
Sci Transl Med. 2019 Apr 17;11(488):. (PMID: 30996080)
Nat Immunol. 2022 Aug;23(8):1208-1221. (PMID: 35879451)
Nat Struct Mol Biol. 2021 Jun;28(6):460-462. (PMID: 34040230)
Nat Commun. 2016 Aug 25;7:12626. (PMID: 27558897)
Front Pediatr. 2022 Sep 08;10:930119. (PMID: 36160781)
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. (PMID: 31520073)
Mol Cell. 2016 Feb 18;61(4):507-519. (PMID: 26876937)
Pharmacol Ther. 2021 Mar;219:107709. (PMID: 33091428)
Trends Cell Biol. 2018 Feb;28(2):113-127. (PMID: 29103884)
Immunol Cell Biol. 2022 Oct;100(9):718-730. (PMID: 36005900)
J Autoimmun. 2006 May;26(3):165-71. (PMID: 16621447)
Front Genet. 2018 Aug 03;9:299. (PMID: 30123242)
Cell. 2020 Jun 25;181(7):1582-1595.e18. (PMID: 32492408)
Methods Enzymol. 2015;560:161-85. (PMID: 26253971)
Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2203318119. (PMID: 35939687)
J Neurol. 2019 Nov;266(11):2699-2709. (PMID: 31321514)
Nucleic Acids Res. 2016 Jun 2;44(10):e91. (PMID: 26896799)
Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308)
Nat Chem Biol. 2014 Feb;10(2):93-5. (PMID: 24316715)
PLoS Pathog. 2016 Jun 30;12(6):e1005701. (PMID: 27362483)
J Biol Chem. 1994 Jul 1;269(26):17697-704. (PMID: 8021282)
J Rheumatol. 2001 Aug;28(8):1764-71. (PMID: 11508577)
Nat Chem Biol. 2011 Oct 16;7(12):885-7. (PMID: 22002720)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Cell Mol Gastroenterol Hepatol. 2020;10(4):747-761. (PMID: 32634481)
Nature. 2012 Apr 29;485(7397):201-6. (PMID: 22575960)
Cell. 2012 Jun 22;149(7):1635-46. (PMID: 22608085)
Biofactors. 2009 Nov-Dec;35(6):474-83. (PMID: 19904719)
Nature. 2017 Aug 17;548(7667):338-342. (PMID: 28792938)
Annu Rev Cell Dev Biol. 2017 Oct 6;33:319-342. (PMID: 28759256)
Mol Genet Genomic Med. 2020 Sep;8(9):e1298. (PMID: 32583611)
فهرسة مساهمة: Keywords: CD40 ligand; RNA methylation; T cell activation; adaptive immunity; autoimmunity; epitranscriptomics
تواريخ الأحداث: Date Created: 20230729 Latest Revision: 20230731
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10376055
DOI: 10.3390/biology12071004
PMID: 37508433
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-7737
DOI:10.3390/biology12071004